Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of MenACWY conjugate vaccine vs polysaccharide vaccine in children
2004-001896-21Phase 2Completed
- Sponsor
- Chiron Corporation
- Start
- Sep 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of meningococcal group A, C, W-135 and Y conjugate vaccine in meningococcal disease (2 arms), sponsored by Chiron Corporation. Primary endpoints: Primary immunogenicity endpoint (age 36 to <60 months) and Functional immune response GMT comparison. Started Sep 2004; status: completed.
02
Drugs
meningococcal group A, C, W-135 and Y conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2004-001896-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001896-21.